Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04936776 · ClinicalTrials.gov registry record

Pediatric Vaccinations

A clinical trial, sponsored by NYU Langone Health.

Completed
Registry status
1,034
Enrollment target

NCT04936776 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 1,034 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04936776 has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
1,034 participants
Enrollment target

Study Summary

As the Covid-19 pandemic hit New York City in the spring of 2020, many families were home-bound due to the city-wide lockdown. As a result, families in New York City were unable to attend their child's healthcare appointments and many young children did not receive their regularly-scheduled vaccinations. Parts of the city-wide lockdown did eventually lift in the summer of 2020 as positive Covid-19 virus rates declined in NYC. However, regularly scheduled vaccination rates (non-Covid-related) remain low. Yet, it is critical that young children receive their mandatory vaccines in a timely manner to decrease the chance of contracting preventable illnesses. Thus, the investigators seek to increase vaccination rates among children ages 0-2 years in Sunset Park Brooklyn.

Interventions

  • BEHAVIORAL Text messaging

Trial Details

FieldValue
Enrollment Target 1,034 participants
Start Date 2021-02-09
Est. Completion 2024-01-02

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT04936776

The ClinicalTrials.gov registry entry for NCT04936776 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,034 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Text messaging is the first listed.

NCT04936776 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04936776 about?

NCT04936776 is a clinical study titled "Pediatric Vaccinations". As the Covid-19 pandemic hit New York City in the spring of 2020, many families were home-bound due to the city-wide lockdown. As a result, families in New York City were unable to attend their child's healthcare appointments and many young children did not receive their regularly-scheduled vaccinat...

What is the current status of trial NCT04936776?

This trial is currently completed. The enrollment target is 1,034 participants. The study started on 2021-02-09. Estimated completion is 2024-01-02.

What interventions are being tested in trial NCT04936776?

The interventions under investigation include: Text messaging (BEHAVIORAL).

Who is sponsoring clinical trial NCT04936776?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.